Search results for "PSYCHOPATHOLOGY"

showing 10 items of 301 documents

Gender-specific associations of depression with positive and negative symptoms in acute schizophrenia

2006

This clinical study analyzed gender-specific relationships of depression with other psychopathological and clinical variables in hospitalized patients with schizophrenia. During clinical routine treatment 119 inpatients with acute schizophrenia (DSM-IV) were investigated with the Calgary Depression Rating Scale for Schizophrenia (CDSS), the Clinical Global Impressions (CGI), and the Positive and Negative Syndrome Scale (PANSS). Depression scores of 77 male and 42 female patients (mean age 31.6+/-10.3 years) were related to background variables and to positive and negative symptom scores. Mean CDSS (5.8+/-5.6) and PANSS scores (total 76.9+/-22.1, positive symptoms 17.6+/-7.6, negative sympto…

AdultMalemedicine.medical_specialtyPsychosisAdolescentAcute schizophreniaRating scaleInternal medicinemental disordersmedicineHumansBiological PsychiatryDepression (differential diagnoses)AgedPsychiatric Status Rating ScalesPharmacologySex CharacteristicsPositive and Negative Syndrome ScaleDepressionLength of StayMiddle Agedmedicine.diseaseAntidepressive AgentsHospitalizationSchizophreniaAcute DiseaseSchizophreniaRegression AnalysisFemaleSchizophrenic PsychologyPsychologyAntipsychotic AgentsPsychopathologyClinical psychologySex characteristicsProgress in Neuro-Psychopharmacology and Biological Psychiatry
researchProduct

Attitude towards adherence in patients with schizophrenia at discharge

2009

Abstract Background Purpose of the present study was to assess the attitude towards adherence at discharge and to verify its predictability using anamnestic and sociodemographic variables, factors influencing clinical treatment as well as the medical treatment applied. Methods Attitude towards adherence was evaluated in 369 inpatients with schizophrenic spectrum disorders within a naturalistic multicenter trial using the Compliance Rating Scale (CRS) by Kemp. Biweekly ratings of the PANSS, UKU and the Subjective Well-being under Neuroleptic Treatment Scale (SWN-K) were applied. Logistic regression and CART analyses were used to determine significant predictor variables for the attitude towa…

AdultMalemedicine.medical_specialtyPsychosisTime Factorsmedicine.drug_classmedicine.medical_treatmentAtypical antipsychoticLogistic regressionStatistics NonparametricMedication Adherence03 medical and health sciences0302 clinical medicineRating scaleSurveys and QuestionnairesMulticenter trialmedicinePsychoeducationHumansPsychiatryBiological PsychiatryRetrospective StudiesPsychiatric Status Rating ScalesMiddle Agedmedicine.diseasePatient Discharge3. Good health030227 psychiatryPsychiatry and Mental healthSchizophreniaSchizophreniaFemaleSchizophrenic PsychologyPsychologyAttitude to Health030217 neurology & neurosurgeryFollow-Up StudiesClinical psychologyPsychopathologyJournal of Psychiatric Research
researchProduct

The benefit from whole body acupuncture in major depression.

2000

Background: In a single-blind placebo-controlled study design we investigated the efficacy of acupuncture additionally applied to drug treatment in major depression. Methods: We randomly included 70 inpatients with a major depressive episode in three different treatment groups: verum acupuncture, placebo acupuncture and a control group. All three groups were pharmacologically treated with the antidepressant mianserin. The verum group received acupuncture at specific points considered effective in the treatment of depression. The placebo group was treated with acupuncture at non-specific locations and the control group received pharmacological treatment plus clinical management. Acupuncture …

AdultMalemedicine.medical_specialtyTime FactorsAcupuncture TherapyMianserinPlaceboSeverity of Illness Indexlaw.inventionRandomized controlled triallawInternal medicineSeverity of illnessAcupunctureMedicineHumansSingle-Blind MethodMajor depressive episodeAgedPsychiatric Status Rating ScalesDepressive Disorder MajorDiazepambusiness.industryMiddle AgedMianserinSurgeryClinical trialPsychiatry and Mental healthClinical PsychologyCross-Sectional StudiesTreatment OutcomeAnti-Anxiety AgentsAntidepressive Agents Second-GenerationFemalemedicine.symptombusinessPsychopathologymedicine.drugJournal of affective disorders
researchProduct

The role of personality disorders on drug dependence treatment outcomes following inpatient detoxification

2004

AbstractAimsThe present 6 month follow-up study was conducted to investigate the possible influence of comorbid personality disorders on drug treatment, as well as associated psychopathology and HIV-related risk behaviors outcomes.Subjects and methodsData were collected initially from a consecutive sample of 74 patients with a diagnosis of opiate abuse or dependence, admitted for inpatient detoxification.ResultDuring intake, 80.9% of patients reported at least one HIV-related risk behavior in the previous 6 months. Not using condoms during sexual intercourse was the most common and the only risk behavior that showed a statistically significant reduction over the follow-up period. A total of…

AdultMalemedicine.medical_specialtymedia_common.quotation_subjectPsychological interventionHIV InfectionsComorbidityPersonality Disorders03 medical and health sciencesRisk-Taking0302 clinical medicineAcquired immunodeficiency syndrome (AIDS)medicineHumansPersonalityPsychiatrymedia_commonAddictionOpioid-Related Disordersmedicine.diseasePersonality disorders030227 psychiatryHospitalizationPsychiatry and Mental healthSexual intercourseTreatment OutcomeFemaleOpiatePsychologyRisk Reduction Behavior030217 neurology & neurosurgeryFollow-Up StudiesPsychopathologyEuropean Psychiatry
researchProduct

Risperidone in the Treatment of Disorders with a combined Psychotic and Depressive Syndrome - A Functional Approach

1992

In vitro receptor-binding profiles and in vivo pharmacological studies have shown risperidone to be a potent mixed serotonin-S2 dopamine-D2-like receptor antagonist. While anti-D2 activity may relate to the antipsychotic potency of neuroleptic drugs, an antidepressive efficacy of substances with anti-S2 activity has been suggested. In an open pilot-study, ten patients with schizodepressive disorders or a DSM-III-R diagnosis of psychotic major depressive episodes were treated with risperidone (2-10 mg/d) for six weeks. Weekly psychopathological evaluation was performed, including BPRS, SANS, SAPS, VAS scales, and AIMS and UKU for the assessment of side-effects. Generally, the psychotic syndr…

AdultMalemedicine.medical_specialtymedicine.drug_classmedicine.medical_treatmentPiperidinesInternal medicineHumansMedicinePotencyPharmacology (medical)AntipsychoticDepression (differential diagnoses)AgedPsychiatric Status Rating ScalesDepressive DisorderRisperidonebusiness.industryDopamine antagonistIsoxazolesSyndromeGeneral MedicineMiddle AgedRisperidoneReceptor antagonistBiperidenPsychiatry and Mental healthPsychotic DisordersAnesthesiaFemalebusinessAntipsychotic AgentsPsychopathologymedicine.drugPharmacopsychiatry
researchProduct

Effectiveness of cognitive-behavioral group therapy for patients with hypochondriasis (health anxiety)

2014

Cognitive behavioral therapy (CBT) has been shown to be highly effective in the treatment of health anxiety. However, little is known about the effectiveness of group CBT in the treatment of health anxiety. The current study is the largest study that has investigated the effectiveness of combined individual and group CBT for patients with the diagnosis of hypochondriasis (N=80). Therapy outcomes were evaluated by several questionnaires. Patients showed a large improvement on these primary outcome measures both post-treatment (Cohen's d=0.82-1.08) and at a 12-month follow-up (Cohen's d=1.09-1.41). Measures of general psychopathology and somatic symptoms showed significant improvements, with …

AdultMalemedicine.medical_treatmentbehavioral disciplines and activitiesGroup psychotherapyCognitionPrimary outcomeSurveys and QuestionnairesAmbulatory CaremedicineHumansTherapy OutcomeAnalysis of VarianceCognitive Behavioral TherapyCognitionSelf ConceptHypochondriasisCognitive behavioral therapyPsychiatry and Mental healthClinical PsychologyGeneral psychopathologyTreatment OutcomePsychotherapy GroupAnxietyFemalemedicine.symptomPsychologyAttitude to HealthClinical psychologyJournal of Anxiety Disorders
researchProduct

Residential Surrounding Greenspace and Mental Health in Three Spanish Areas

2020

Exposure to greenspace has been related to improved mental health, but the available evidence is limited and findings are heterogeneous across different areas. We aimed to evaluate the associations between residential exposure to greenspace and specific psychopathological and psychosomatic symptoms related to mental health among mothers from a Spanish birth cohort. Our study was based on data from 1171 women participating in two follow-ups of a population-based cohort in Valencia, Sabadell, and Gipuzkoa (2004&ndash

AdultParksHealth Toxicology and MutagenesisPopulationlcsh:MedicineSymptom Checklist 90AnxietyEnvironment010501 environmental sciences01 natural sciencesArticlepsychiatric disorderCohort Studies03 medical and health sciences0302 clinical medicineSDG 3 - Good Health and Well-beingEnvironmental healthmedicineHumans030212 general & internal medicineeducation0105 earth and related environmental scienceseducation.field_of_studylcsh:RparksPublic Health Environmental and Occupational HealthnatureMental illnessmedicine.diseaseMental IllnessMental healthmental illnessNatureMental HealthCohortAnxietyFemalemedicine.symptomPsychologySomatizationpsychosomatic symptomsPsychopathology
researchProduct

Prediction of Course in Major Depression. Does Psychopathology Predict Future Drug Intake or Relapse?

1988

AdultPsychiatric Status Rating ScalesDepressive Disordermedicine.medical_specialtybusiness.industryGeneral MedicineMiddle AgedPrognosisPsychiatry and Mental healthRecurrencemedicineHumansPharmacology (medical)Drug intoxicationPsychiatrybusinessDepression (differential diagnoses)Clinical psychologyPsychopathologyPharmacopsychiatry
researchProduct

Orexin and sleep quality in anorexia nervosa: Clinical relevance and influence on treatment outcome

2015

Background and aims Orexins/hypocretins are orexigenic peptides implicated in the regulation of feeding behavior and the sleep/wake cycle. Little is known about the functioning of these peptides in anorexia nervosa (AN). The aims of the current study were to evaluate the extent to which orexin-A might be linked to sleep and treatment outcome in AN. Method Fasting plasma orexin-A concentrations were measured in 48 females with AN at the start of a day hospital treatment and in 98 normal-eater/healthy-weight controls. The Pittsburgh Sleep Quality Index was administered at the beginning of the treatment as a measure of sleep quality. Other psychopathological variables were evaluated with the S…

AdultSleep Wake Disorders050103 clinical psychologymedicine.medical_specialtyOrexin-AAnorexia NervosaEndocrinology Diabetes and MetabolismSleep Wake DisordersAnorexiaPittsburgh Sleep Quality Index03 medical and health sciences0302 clinical medicineEndocrinologyInternal medicinemental disordersmedicineHumans0501 psychology and cognitive sciencesTreatment outcomePsychiatryPartial hospitalizationBiological PsychiatryOrexinsEndocrine and Autonomic Systemsdigestive oral and skin physiology05 social sciencesCase-control studyAnorexia nervosaFeeding BehaviorSleep in non-human animalsOrexinPsychiatry and Mental healthTreatment OutcomeAnorexia nervosa (differential diagnoses)Case-Control StudiesFemalemedicine.symptomSleepPsychology030217 neurology & neurosurgeryPsychopathologyPsychoneuroendocrinology
researchProduct

Alexithymia and facial emotion recognition in patients with eating disorders

2006

Objective: Patients with anorexia or bulimia nervosa are reported to show high levels of alexithymia and to have difficulties recognizing facially displayed emotions. The current study tested whether it could be that facial emotion recognition is a basic skill that is independent from alexithymia. Method: We assessed emotion recognition skills and alexithymia in a group of 79 female inpatients with eating disorders and compared them with a group of 78 healthy female controls. Instruments used were the Toronto Alexithymia Scale, the Facially Expressed Emotion Labeling (FEEL) test, and the revised Symptom Check List (SCL-90-R). Results: There were no significant differences between patients a…

Adultmedia_common.quotation_subjectDevelopmental psychologyFeeding and Eating DisordersToronto Alexithymia ScaleAlexithymiaSurveys and QuestionnairesmedicineHumansExpressed emotionPersonalityAffective Symptomsmedia_commonObserver VariationFacial expressionmedicine.diagnostic_testBulimia nervosaRecognition Psychologymedicine.diseaseFacial ExpressionAffectPsychiatry and Mental healthEating disordersFemalePsychologyClinical psychologyPsychopathologyInternational Journal of Eating Disorders
researchProduct